Psigryph Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 9

Psigryph General Information

Description

Developer of a biodegradable delivery vehicle designed to transport microscopic bioactive compounds into living cells. The company offers a patented, non-toxic, sour cherry-derived nanotechnology, enabling the agricultural, food, health, and biopharma industries, to enhance performance while minimizing environmental impact.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • C/O GowlingWLG 345 King Street West
  • Suite 600
  • Kitchener, Ontario N2G 0C5
  • Canada
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Corporate Office
  • C/O GowlingWLG 345 King Street West
  • Suite 600
  • Kitchener, Ontario N2G 0C5
  • Canada

Psigryph Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Psigryph Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Accelerator/Incubator 01-Jan-2026 Completed Generating Revenue
10. Accelerator/Incubator 01-Jan-2025 Completed Generating Revenue
9. Seed Round Completed Generating Revenue
8. Accelerator/Incubator 25-Nov-2024 Completed Generating Revenue
7. Angel (individual) 15-Jan-2024 Completed Startup
6. Accelerator/Incubator 01-Dec-2022 Completed Startup
5. Seed Round 09-Aug-2022 Completed Startup
4. Accelerator/Incubator 04-Aug-2022 Completed Startup
3. Accelerator/Incubator 01-Mar-2021 Completed Startup
2. Accelerator/Incubator 01-Jan-2021 Completed Startup
To view Psigryph’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Psigryph Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a biodegradable delivery vehicle designed to transport microscopic bioactive compounds into living cells. T
Drug Delivery
Kitchener, Canada
4 As of 2026

Vancouver, Canada
 

Medford, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Psigryph Competitors (8)

One of Psigryph’s 8 competitors is Acuitas Therapeutics, a Corporation company based in Vancouver, Canada.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Acuitas Therapeutics Corporation Vancouver, Canada
GreenLight Biosciences Private Equity-Backed Medford, MA
Arbutus Biopharma Corporation Warminster, PA
RNAiSSANCE AG Venture Capital-Backed Saint Louis, MO
Amway Corporation Ada, MI
You’re viewing 5 of 8 competitors. Get the full list »

Psigryph Patents

Psigryph Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2022513081-A Nanofiber derived from plant tissue Active 15-Nov-2018
JP-7510695-B2 Nanofibers derived from plant tissue Active 15-Nov-2018
AU-2019378099-A1 Plant tissue-derived nanofibres Active 15-Nov-2018
AU-2019378099-B2 Plant tissue-derived nanofibres Active 15-Nov-2018
CA-3120002-A1 Plant tissue-derived nanofibres Pending 15-Nov-2018 D01C1/02
To view Psigryph’s complete patent history, request access »

Psigryph Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Psigryph Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Hatch Fairhope Accelerator/Incubator
Alabama Biomanufacturing Labs Accelerator/Incubator
HudsonAlpha AgTech Accelerator Accelerator/Incubator Minority
Foresight Canada Accelerator/Incubator
Boundless Accelerator Accelerator/Incubator Minority
You’re viewing 5 of 9 investors. Get the full list »

Psigryph FAQs

  • When was Psigryph founded?

    Psigryph was founded in 2018.

  • Where is Psigryph headquartered?

    Psigryph is headquartered in Kitchener, Canada.

  • What is the size of Psigryph?

    Psigryph has 4 total employees.

  • What industry is Psigryph in?

    Psigryph’s primary industry is Drug Delivery.

  • Is Psigryph a private or public company?

    Psigryph is a Private company.

  • What is Psigryph’s current revenue?

    The current revenue for Psigryph is .

  • How much funding has Psigryph raised over time?

    Psigryph has raised $833K.

  • Who are Psigryph’s investors?

    Hatch Fairhope, Alabama Biomanufacturing Labs, HudsonAlpha AgTech Accelerator, Foresight Canada, and Boundless Accelerator are 5 of 9 investors who have invested in Psigryph.

  • Who are Psigryph’s competitors?

    Acuitas Therapeutics, GreenLight Biosciences, Arbutus Biopharma, RNAiSSANCE AG, and Amway are some of the 8 competitors of Psigryph.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process